- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Directorate Change <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - PULMICORT RESPULES® US PATENT LITIGATION DECISION <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ to acquire Actavis' US respiratory portfolio <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - BT Group PLC - BT agrees definitive terms to acquire EE <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">BT.L</Origin>
AnnouncementREG - AstraZeneca PLC - Final Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
AnnouncementREG - AstraZeneca PLC - Final Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - AstraZeneca PLC - Final Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
AnnouncementREG - AstraZeneca PLC - Final Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - AstraZeneca PLC - Notice of Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - LYNPARZA APPROVED BY THE US FDA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - LYNPARZAT APPROVED IN THE EUROPEAN UNION <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - MOVENTIG approved in the EU for OIC <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Jury verdict favours AZ in Nexium litigation <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - New Drug Application for IRESSA accepted by US FDA <Origin Href="QuoteRef">AZN.L</Origin>
Announcement